VANGUARD GROUP INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 81 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$7,402,241
+8.1%
600,344
+7.8%
0.00%
Q2 2023$6,848,615
+21.5%
556,798
+21.4%
0.00%
Q1 2023$5,635,223
-16.4%
458,521
-22.0%
0.00%
Q4 2022$6,738,720
+195.6%
588,021
-3.3%
0.00%
Q3 2022$2,280,000
-37.0%
607,804
-0.1%
0.00%
Q2 2022$3,619,000
-5.9%
608,2040.0%0.00%
Q1 2022$3,847,000
+59.6%
608,204
-1.4%
0.00%
Q4 2021$2,411,000
-19.3%
616,848
-0.3%
0.00%
Q3 2021$2,988,000
-24.4%
618,6090.0%0.00%
Q2 2021$3,953,000
+1.8%
618,6090.0%0.00%
Q1 2021$3,885,000
-4.5%
618,609
+4.7%
0.00%
Q4 2020$4,070,000
+102.3%
590,622
+17.4%
0.00%
Q3 2020$2,012,000
+20.1%
503,0270.0%0.00%
Q2 2020$1,675,000
+54.8%
503,0270.0%0.00%
Q1 2020$1,082,000
-31.7%
503,0270.0%0.00%
Q4 2019$1,584,000
-28.7%
503,027
+1.6%
0.00%
Q3 2019$2,222,000
-2.6%
495,027
+31.3%
0.00%
Q2 2019$2,281,000
+45.9%
377,010
+67.6%
0.00%
Q1 2019$1,563,000
+85.2%
224,930
+2.8%
0.00%
Q4 2018$844,000
-71.0%
218,757
-60.0%
0.00%
Q3 2018$2,913,000
+7.3%
546,632
-1.1%
0.00%
Q2 2018$2,714,000
-43.7%
552,852
-7.6%
0.00%
Q1 2018$4,817,000
-28.1%
598,410
-8.5%
0.00%
Q4 2017$6,703,000
-24.6%
653,931
+7.0%
0.00%
Q3 2017$8,885,000610,9970.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Newtyn Management, LLC 362,335$3,714,0000.57%
Rubric Capital Management LP 410,244$4,205,0000.52%
WITTENBERG INVESTMENT MANAGEMENT, INC. 83,811$859,0000.37%
Yakira Capital Management, Inc. 83,969$861,0000.28%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$153,0000.10%
STONEBRIDGE CAPITAL MANAGEMENT INC 18,550$200,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 66,498$681,0000.05%
Cannell & Co. 75,467$774,0000.03%
Trexquant Investment LP 21,347$219,0000.02%
PDT Partners, LLC 58,004$595,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders